Product review · Updated September 30, 2026
Geek & Gorgeous Power Peptides review: four technology figures are not one copper percentage
Matrixyl, TEGO and X50 numbers stay attached to their named technologies and the evidence level described for each.
Editorial source review, with no clinician sign-off or firsthand treatment experience claimed.
Geek & Gorgeous describes Power Peptides through four peptide technologies and several small percentages. Reading those figures as if each measured the same active would lose the product’s own distinctions. The copper-containing X50 technology is one part of the description, while Matrixyl and TEGO refer to other named technologies in the serum.
This review follows the manufacturer page checked on September 30, 2026, including its complete online declaration and its attributions to technology-manufacturer data. FDA’s labeling explanation supplies context for interpreting ingredient names rather than reconstructing quantities. We did not acquire the underlying full technology reports, inspect a bottle or measure the finished serum.
In this article
Power Peptides is the object, not four separate test products
The page calls Power Peptides a milky peptide serum containing four technologies. Its firmness and bounce language describes the manufacturer’s intended appearance benefits. It does not mean this review observed those results, and it does not identify four controlled experiments conducted on the finished product. The formulation is one named serum with several described technology inputs. Product identity.
That distinction keeps the later evidence discussion anchored. A technology report may describe an input without testing the bottle sold under the Power Peptides name. The Skin Deva review is a separate blend record for further reading. It is linked as navigation, without treating either blend as a clinical comparator for the other.
The 5% summary concerns two Matrixyl technologies
The page’s Matrixyl discussion specifies 3% Matrixyl 3000 and 2% Matrixyl synthe’6. It identifies Palmitoyl Tripeptide-1 with Palmitoyl Tetrapeptide-7 for the first technology and Palmitoyl Tripeptide-38 for the second. The displayed 5% Matrixyl summary therefore belongs to those named technologies; it is not a statement of 5% copper peptide. Matrixyl descriptions.
The brand attributes benefits in this passage to manufacturer data. The acquired material is that attribution and explanation, not the full original reports. Adding the two stated technology figures does not turn them into a pure-active assay or a demonstrated overall serum result. The public-record comparison provides additional context for keeping unlike numbers in their own categories.
TEGO’s cited participant number has its own owner
For TEGO PEP 4-17, the page states that Power Peptides contains 4%. Its explanation refers to a 60-person in-vivo test conducted by the technology manufacturer and describes that as a studied level. The selected passage does not establish that those people tested Geek & Gorgeous’s finished serum. The participant number should remain attached to the attributed technology test. TEGO evidence wording.
Without the complete report, this review cannot supply the study’s missing comparator or methods. It also cannot pool that headcount with figures elsewhere on the page. The study-endpoints article is relevant onward reading because a participant count only becomes interpretable when the actual tested preparation and measured result are identified.
X50’s tiny figure is still a technology claim
The fourth technology is X50 Antiaging. The manufacturer page names its copper ingredient as Copper Palmitoyl Heptapeptide-14 and describes an encapsulated delivery system with Heptapeptide-15 Palmitate. It states 0.001% as the amount of the named technology used in this serum. That figure should not be rewritten as an independently measured fraction of isolated copper active. X50 passage.
The delivery explanation is also a manufacturer claim, not an absorption experiment performed for this review. Recognizing an ingredient name does not verify a targeting mechanism or permit substitution of a different copper-peptide identity. The documentation supplies a named technology and a reported technology level; it leaves analytical purity and finished-product comparative performance unresolved.
The declaration connects the names to one formulation
The complete captured list names the Matrixyl-associated peptides, Tetrapeptide-21, Copper Palmitoyl Heptapeptide-14 and Heptapeptide-15 Palmitate among many other components. Water, glycerin and several additional substances also appear. This is evidence of the manufacturer’s declared multi-ingredient serum, rather than a formula consisting only of the headline technologies. Complete online list.
FDA’s guide explains that proprietary-mixture components still require individual ingredient identification, subject to its specified exceptions. A declared name and a proprietary technology level thus answer different questions. The former helps identify components; it does not define every component’s share of the latter. FDA mixture and ordering guidance. No recipe or active conversion is derived from this list.
List position cannot certify the loading of the copper constituent
The FDA guide permits ingredients at 1% or less to be listed in a flexible order after higher-concentration ingredients; color additives have a separate ordering provision. Those exceptions prevent a simplistic ranking of small ingredient amounts from their positions. They do not establish which exception applies to each Power Peptides component or reveal undisclosed copper loading. Labeling explanation.
This matters especially when a page supplies a small technology figure beside a long ingredient declaration. Neither the figure nor the list order resolves the portion attributable to its copper constituent. The grade-and-purity guide addresses a further distinction: ingredient identification is not a substitute for analytical evidence behind a purity or potency statement.
The useful result is a technology-by-technology reading
The examined page documents four named technologies, their reported levels and a complete ingredient list. It also attributes portions of its benefit discussion to technology-manufacturer evidence. The review does not combine those figures into a total copper percentage, verify the underlying full reports or establish a finished-serum advantage over another brand. Manufacturer record.
For another formulation record, see the Acure review. Its inclusion is an onward reading choice, not a performance comparison. The practical value of this record is its specific naming: each number can be attached to the technology it describes, while the copper constituent’s measured share and the complete serum’s independently verified outcomes remain unanswered in the acquired evidence.
Sources behind this reading
- Power Peptides ↗Official brand-specific product or manufacturer-context primary · Checked September 30, 2026
- FDA Cosmetic Labeling Guide ↗Regulator primary: selected label passages · Checked September 30, 2026